MarketInOut Stock Screener Log In | Sign Up
 

Arecor Therapeutics Plc

LSE • Healthcare • Biotechnology • Quote as of 06/12/2026
Arecor Therapeutics Plc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization24.54 mln
Float21.07 mln
Earnings Date09/24/2026

EPS

2.06
Solid

P / E

29.35
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-1.33
Manipulation likely

Relative Strength

5 / 100
Severely lagging

Debt / Equity

0.01
Debt-free

Business Description

Arecor Therapeutics is a UK-based clinical-stage biotech company focused on improving existing medicines and creating new treatments for people with diabetes and other conditions. Using its proprietary Arestat platform, the company reformulates therapeutic products to make them more effective, working both independently and in partnership with other pharmaceutical firms. Its pipeline includes faster-acting and more concentrated insulin formulations, a treatment for severe low blood sugar episodes, and collaborative projects exploring oral GLP-1 therapies and insulins designed for implantable pumps.

Key Fundamentals

EPS2.06
P/E29.35
ROE13.59
RPS0.05
ROIC-161
ROA9.02
EBITDA, mln1.22
EV / EBITDA15.48
EV / EBIT18.79
Revenue, mln1.71
EV / Revenue11.02

Financial Strength

Altman Z-Score2.95
Piotroski F-Score 6 / 9
Beneish M-Score-1.33

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -13.04% 2 / 100   
1 Month -12.77% 8 / 100   
2 Months -13.87% 12 / 100   
6 Months -26.47% 6 / 100   
1 Year 37.93% 79 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us